Home › Cancer (all types) › Nevada
Cancer (all types) clinical trials in Nevada
13 studies for Cancer (all types) are looking for participants at sites in Nevada.
Cities in Nevada
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Comprehensive Cancer Centers of Nevada ( Site 1109), Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07209111A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Reno
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- Oncology Las Vegas - Henderson, Henderson
- University Medical Center of Southern Nevada, Las Vegas
- Sunrise Hospital and Medical Center, Las Vegas
- and 5 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Women's Cancer Center of Nevada, Las Vegas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Renown Regional Medical Center /ID# 276049, Reno
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT07005102Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 2, 2026 · NCT06014658TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Cancer Care Specialists - Reno, Reno
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Feb 24, 2026 · NCT06207032GEMINI-NSCLC: NSCLC Biomarker Study
- OptumCare Cancer Care, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- Cancer Care Specialists Reno, Reno
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2025 · NCT05997017Prospective Study of oncRNA Stratification of Cancer by Size and Stage
- Renown Health, Reno
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 18, 2025 · NCT05833360From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.